Anavex Life Sciences Corp. (AVXL) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Anavex Life Sciences Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.617 -- 00:00:06.703 Good morning, and welcome to the Anovex Life Sciences Fiscal 2024 Fourth 00:00:06.703 -- 00:00:11.248 Quarter Conference Call. My name is Clint Tomlinson, and I will be your host for today's 00:00:11.248 -- 00:00:15.733 call. At this time, all participants are in a listen-only mode. 00:00:15.733 -- 00:00:18.696 Later, we will conduct a question and answer session. 00:00:18.696 -- 00:00:22.440 During this session, if you would like to ask a question, please use the Q&A box or raise 00:00:22.440 -- 00:00:24.502 your hand. 00:00:24.502 -- 00:00:27.326 Please note that this conference is being recorded. 00:00:27.326 -- 00:00:31.638 The call will be available for replay on Anovex's website at www. 00:00:31.638 -- 00:00:33.638 With 00:00:33.941 -- 00:00:38.749 us today is Dr. Christopher Misling, President and Chief Executive Officer, and Sandra 00:00:38.749 -- 00:00:42.214 Burnish, Principal Financial Officer. 00:00:42.214 -- 00:00:45.539 Before we begin, please note that during this conference call, the company will make 00:00:45.539 -- 00:00:48.183 some projections and forward-looking statements. 00:00:48.183 -- 00:00:52.249 These statements are only predictions based on current information and expectations and 00:00:52.249 -- 00:00:55.053 involve a number of risks and uncertainties. 00:00:55.053 -- 00:00:58.773 We encourage you to review the company's filings with the SEC. 00:00:58.773 -- 00:01:03.879 This includes without limitation the company's forms 10-K, 10-Q, which identify the 00:01:03.879 -- 00:01:08.905 specific factors that may cause actual results or events to 00:01:08.905 -- 00:01:12.630 differ materially from those described in these forward-looking statements. 00:01:12.630 -- 00:01:16.554 These factors may include witho...